United States Gene Prediction Tools Market Opportunities in Drug Discovery and Diagnostics | Market Share and Competitive Landscape 2025.

"The Global gene prediction tool market is expected to reach at a CAGR 18.5% during the forecast period 2024-2031. According to DataM intelligence Report.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/gene-prediction-tool-market?oppratik

United States: Recent Industry Developments:

✅ October 15, 2025: Illumina launched its novel 5-base solution at the ASHG conference in the US, enabling simultaneous detection of genomic variants and DNA methylation for rare disease research and precision medicine breakthroughs.

Japan: Recent Industry Developments:

✅ October 10, 2025: MGI Tech and Genesis Healthcare in Japan signed a strategic collaboration MoU to advance precision health using MGI's DNBSEQTM sequencing technology, aiming to enhance genomic research and healthcare solutions locally.

Mergers & Acquisitions (M&A):

2025-09-02: SeqOne announced the acquisition of Congenica to create a larger AI-powered clinical genomics software leader serving labs and hospitals.

2025-09-15: Limbus (varvis®) acquired Nostos Genomics to combine AI-driven variant interpretation and clinical-grade genomic workflows.

2025-08-07: 10x Genomics agreed to acquire Scale Biosciences, expanding single-cell and spatial analysis capabilities that feed downstream genomics/interpretation workflows.

2025-06-18: Delta Electronics (via a Prenetics divestment) moved to acquire ACT Genomics in a transaction valued up to US$71.78M, strengthening clinical genomics and oncology testing capabilities.

2025-05-29: Mapmygenome completed the acquisition of Canada's Microbiome Insights, adding sequencing/analysis lab capacity and IP that support expanded genomics and interpretation services.

Recent Investments:

✅ October 2025: Increasing investments focus on AI-driven genomic research and precision medicine platforms enhancing gene prediction accuracy and cloud-based solutions, though specific funding rounds are typically within larger biotech firms adapting gene prediction tools.

Key Players:

e Thermo Fisher Scientific Inc., Softberry, Inc., Illumina, Inc., QIAGEN, GenScript, DNASTAR, BGI,Geneious, Sangamo Therapeutics and Takara Bio Inc..

Research Process:

Both primary and secondary data sources have been used in the Global gene prediction tool Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=gene-prediction-tool-market?oppratik

DataM Intelligence has published a new research report on "gene prediction tool Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Market Segments:

By Component- Software, Services

By Method- Similarity Based Searches, Ab-Initio Prediction

By Application- Drug Discovery, Genetic Disorder Diagnosis, Biomedical Research, Others

By End User- Hospitals, Biotechnology and Life Science Companies, Others

Latest Industry News:

✅ September 2025: The global gene prediction tool market is valued at about USD 237 million in 2025 and is expected to grow at a CAGR of around 18.7%, reaching over USD 1.1 billion by 2034 due to advancements in computational biology and AI integration.

✅ Advances in AI and machine learning are driving growth by improving gene prediction algorithms used in drug discovery, diagnostics, and personalized medicine.

✅ Strategic collaborations between gene prediction tool firms and health organizations are accelerating innovation and market penetration.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/gene-prediction-tool-market?oppratik

FDA Approval-

October 2025: No specific FDA approvals related to gene prediction tools have been reported. Most advancements involve AI-driven algorithms and software platforms for genomic research, which typically fall under regulatory oversight of medical devices or software with FDA clearance or approval as applicable.

September 2025: The FDA approved several companion diagnostics and gene signatures used in precision medicine, but no direct approvals of gene prediction tools were noted.

July 2025: The focus was on approvals for gene editing and sequencing platforms, with no specific new gene prediction software approved during this period.

Key Developments:

June 1, 2023: Illumina Inc. launched the PrimateAI-3D algorithm, an AI tool that predicts disease-causing genetic variants with high accuracy, published in Science on June 2.

January 23, 2023: QIAGEN Digital Insights upgraded its CLC Genomics Workbench Premium, enhancing speed and efficiency in analyzing WES, WGS, and large sequencing data.

May 16, 2022: Geneious Biologics introduced a free online antibody annotation and visualization tool, enabling researchers to analyze antibody sequences easily.

FAQ's

Q1: How fast is the gene prediction tool Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 18.5% from 2024 to 2031

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?oppratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us-

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.